Cervical Volume by Three-Dimensional Ultrasound as a Predictor of Preterm Delivery
NCT ID: NCT00342550
Last Updated: 2023-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
648 participants
OBSERVATIONAL
1998-03-11
2008-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our protocol will attempt to identify prognostic indicators of adverse pregnancy outcome by three-dimensional ultrasound. A maximum of 680 pregnant women with the diagnosis of preterm labor will be prospectively studied to characterize cervical morphology and volume as predictors of preterm delivery risk. These results will be correlated with placental pathology and pregnancy outcome. We will also compare the performance of conventional two-dimensional endovaginal ultrasound with three-dimensional ultrasound findings. This information is expected to improve our understanding about the nature and timing of cervical volume changes in relation to pregnancy outcome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cervical Volume and Prediction of Preterm Labor
NCT06190496
Preterm Labor Prediction by Cervical Contour in Ultrasound
NCT01912508
Is It Possible to Predict Pre Term Labor by Measuring Cervical Length in the Non-pregnant Uterus?
NCT01340352
Detection of Preterm Labour by Cervical Length
NCT04104984
The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery
NCT02021539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our protocol will attempt to identify prognostic indicators of adverse pregnancy outcome by three-dimensional ultrasound. A maximum of 680 pregnant women with the diagnosis of preterm labor will be prospectively studied to characterize cervical morphology and volume as predictors of preterm delivery risk. These results will be correlated with maternal and fetal biological markers, placental pathology and pregnancy outcome. We will also compare the performance of conventional two-dimensional endovaginal ultrasound with three-dimensional ultrasound findings. This information is expected to improve our understanding about the nature and timing of cervical volume changes in relation to pregnancy outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant Women
Pregnant women aged 15 and older between 20 and 35 weeks with singleton gestation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Estimated gestational age between 20 and 35 weeks gestation;
3 Intact membranes;
4\. Signed informed consent for voluntary participation and serial endovaginal scans.
1. Estimated gestational age between 16 and \< 24 weeks gestation;
2. Planned cerclage placement due to increased preterm labor risk (i.e., short cervix or dilated cervix);
3. Intact membranes;
4. Signed informed consent for voluntary participation and serial endovaginal scans.
1. Term gestation (greater than 37 weeks);
2. Intact membranes;
3. Cervical dilatation less than 2 cm;
4. Signed informed consent for voluntary participation and serial endovaginal scans.
1. Term gestation (greater than 37 weeks);
2. Intact membranes;
3. Signed informed consent for voluntary participation and serial endovaginal scans.
Exclusion Criteria
2. Desire not to have vaginal ultrasound scans.
1. Absent fetal cardiac activity;
2. Desire not to have vaginal ultrasound scans.
1. Absent fetal cardiac activity;
2. Desire not to have vaginal ultrasound scans.
1. Absent fetal cardiac activity;
2. Desire not to have vaginal ultrasound scans.
15 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberto Romero, M.D.
Role: PRINCIPAL_INVESTIGATOR
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hutzel Women's Hospital
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ayers JW, DeGrood RM, Compton AA, Barclay M, Ansbacher R. Sonographic evaluation of cervical length in pregnancy: diagnosis and management of preterm cervical effacement in patients at risk for premature delivery. Obstet Gynecol. 1988 Jun;71(6 Pt 1):939-44.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OH98-CH-N016
Identifier Type: -
Identifier Source: secondary_id
999998016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.